Antitumor Compounds from Marine Actinomycetes

被引:220
作者
Olano, Carlos
Mendez, Carmen
Salas, Jose A. [1 ]
机构
[1] Univ Oviedo, Dept Biol Func, E-33006 Oviedo, Spain
关键词
anthracycline; indolocarbazole; macrolide; non-ribosomal peptide synthetase; polyketide synthase; NONRIBOSOMAL PEPTIDE ANTIBIOTICS; BIOSYNTHETIC GENE-CLUSTER; NF-KAPPA-B; STREPTOMYCES-SP; NATURAL-PRODUCTS; A-C; PHYSICOCHEMICAL PROPERTIES; STRUCTURE ELUCIDATION; POLYKETIDE SYNTHASE; CYTOTOXIC COMPOUND;
D O I
10.3390/md7020210
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Chemotherapy is one of the main treatments used to combat cancer. A great number of antitumor compounds are natural products or their derivatives, mainly produced by microorganisms. In particular, actinomycetes are the producers of a large number of natural products with different biological activities, including antitumor properties. These antitumor compounds belong to several structural classes such as anthracyclines, enediynes, indolocarbazoles, isoprenoides, macrolides, non-ribosomal peptides and others, and they exert antitumor activity by inducing apoptosis through DNA cleavage mediated by topoisomerase I or II inhibition, mitochondria permeabilization, inhibition of key enzymes involved in signal transduction like proteases, or cellular metabolism and in some cases by inhibiting tumor-induced angiogenesis. Marine organisms have attracted special attention in the last years for their ability to produce interesting pharmacological lead compounds.
引用
收藏
页码:210 / 248
页数:39
相关论文
共 184 条
[1]   Nuclear factor-κB:: A holy grail in cancer prevention and therapy [J].
Aggarwal, Bharat B. ;
Sethi, Gautam ;
Nair, Asha ;
Ichikawa, Haruyo .
CURRENT SIGNAL TRANSDUCTION THERAPY, 2006, 1 (01) :25-52
[2]   Actinomycete Bacteria Isolated from the Sediments at Coastal and Offshore Area of Nagasaki Prefecture, Japan: Diversity and Biological Activity [J].
Anzai, Kozue ;
Nakashima, Takuji ;
Kuwahara, Natsumi ;
Suzuki, Rieko ;
Ohfuku, Yuko ;
Takeshita, Satoshi ;
Ando, Katsuhiko .
JOURNAL OF BIOSCIENCE AND BIOENGINEERING, 2008, 106 (02) :215-217
[3]   Daryamides A-C, weakly cytotoxic polyketides from a marine-derived actinomycete of the genus Streptomyces strain CNQ-085 [J].
Asolkar, Ratnakar N. ;
Jensen, Paul R. ;
Kauffman, Christopher A. ;
Fenical, William .
JOURNAL OF NATURAL PRODUCTS, 2006, 69 (12) :1756-1759
[4]   Arenamides A-C, Cytotoxic NFκB Inhibitors from the Marine Actinomycete Salinispora arenicola [J].
Asolkar, Ratnakar N. ;
Freel, Kelle C. ;
Jensen, Paul R. ;
Fenical, William ;
Kondratyuk, Tamara P. ;
Park, Eun-Jung ;
Pezzuto, John M. .
JOURNAL OF NATURAL PRODUCTS, 2009, 72 (03) :396-402
[5]   Chalcomycin B, a new macrolide antibiotic from the marine isolate Streptomyces sp B7064 [J].
Asolkar, RN ;
Maskey, RP ;
Helmke, E ;
Laatsch, H .
JOURNAL OF ANTIBIOTICS, 2002, 55 (10) :893-898
[6]   Renaissance in antibacterial discovery from actinomycetes [J].
Baltz, Richard H. .
CURRENT OPINION IN PHARMACOLOGY, 2008, 8 (05) :557-563
[7]   Thiocoraline, a novel depsipeptide with antitumor activity produced by a marine Micromonospora .2. Physico-chemical properties and structure determination [J].
Baz, JP ;
Canedo, LM ;
Puentes, JLF ;
Elipe, MVS .
JOURNAL OF ANTIBIOTICS, 1997, 50 (09) :738-741
[8]   Biosynthetic convergence of salinosporamides A and B in the marine actinomycete Salinispora tropica [J].
Beer, Laura L. ;
Moore, Bradley S. .
ORGANIC LETTERS, 2007, 9 (05) :845-848
[9]   Bioactive microbial metabolites -: A personal view [J].
Bérdy, J .
JOURNAL OF ANTIBIOTICS, 2005, 58 (01) :1-26
[10]  
Bernan V. S, 2004, Current Medicinal Chemistry - Anti-Infective Agents, V3, P181, DOI 10.2174/1568012043353883